XOVR Among Its Peers
End-of-day Nov 18, 2026 · 0 ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.6% | −2.9% | −7.1% | −1.6% | −2.2% | −0.3% | — | — | — | +39.3% |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$70 of every $1,000 in XOVR is Nvidia
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —SPV Exposure to SpaceX LP | — | 16.25% | $1,624.64 | 0 | $204.5M |
| 2 | NVDANvidia | Technology | 7.05% | $704.59 | 570K | $88.7M |
| 3 | GOOGLAlphabet | Communication Services | 5.26% | $526.34 | 236K | $66.2M |
| 4 | METAMETA Platforms | Communication Services | 4.55% | $455.20 | 93K | $57.3M |
| 5 | CARTMaplebear | Technology | 4.42% | $442.04 | 951K | $55.6M |
| 6 | UIUbiquiti | Technology | 4.33% | $433.47 | 83K | $54.6M |
| 7 | —Kalshi | — | 4.22% | $421.85 | 46K | $53.1M |
| 8 | TOSTToast | Technology | 3.81% | $380.85 | 1.4M | $47.9M |
| 9 | SPCXSpace Exploration Technologies | Industrials | 3.79% | $379.04 | 337K | $47.7M |
| 10 | APPAppLovin | Technology | 3.24% | $323.86 | 102K | $40.8M |
| 11 | GMEDGlobus Medical | Healthcare | 2.95% | $295.12 | 531K | $37.1M |
| 12 | NBIXNeurocrine Biosciences | Healthcare | 2.80% | $279.79 | 212K | $35.2M |
| 13 | VEEVVeeva Systems | Technology | 2.64% | $264.03 | 115K | $33.2M |
| 14 | EXELExelixis | Healthcare | 2.63% | $262.59 | 482K | $33.1M |
| 15 | ABNBAirbnb | Consumer Cyclical | 2.52% | $252.03 | 175K | $31.7M |
XOVR has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | NVDA | Nvidia | 7.05% |
| 2 | GOOGL | Alphabet | 5.26% |
| 3 | META | META Platforms | 4.55% |
| 4 | CART | Maplebear | 4.42% |
| 5 | UI | Ubiquiti | 4.33% |
| 6 | TOST | Toast | 3.81% |
| 7 | SPCX | Space Exploration Technologies | 3.79% |
| 8 | APP | AppLovin | 3.24% |
| 9 | GMED | Globus Medical | 2.95% |
| 10 | NBIX | Neurocrine Biosciences | 2.80% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| XOVR | −0.23 | −0.33 | 25.9% | −20.4% | 1.44 | $75 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 21, 2021 | Dec 28, 2021 | $8.73 |
| Dec 21, 2020 | Dec 23, 2020 | $1.65 |
| Dec 19, 2019 | Dec 23, 2019 | $0.0144 |
| Dec 18, 2018 | Dec 20, 2018 | $0.52 |
| Dec 22, 2017 | Dec 28, 2017 | $0.0127 |